Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04228172 · ClinicalTrials.gov registry record

Genotypic Influences on Network Progression in Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by Northwell Health.

Active
Registry status
32
Enrollment target
1
Study location

NCT04228172 is a study of Parkinson's Disease that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 32 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04228172, a study of Parkinson's Disease, is active but no longer recruiting, sponsored by Northwell Health.

ACTIVE NOT RECRUITING
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

In this longitudinal study, the investigators will follow Parkinson's disease (PD) patients with and without glucocerebrosidase (GBA) mutations. The investigators hypothesize that the rate of increase in brain network activity over time (network progression rate) is faster in patients with GBA gene mutations.

Conditions Studied

Parkinson's Disease

Interventions

  • OTHER MRI scan
  • GENETIC DNA/GeneticTesting
  • RADIATION FDG PET scan
  • OTHER Clinical and neuropsychological assessments

Study Locations (1)

New York

  • Feinstein Institutes for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2020-02-24
Est. Completion 2026-02-01

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04228172

The ClinicalTrials.gov registry entry for NCT04228172 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (95% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 4 interventions - of which MRI scan is the first listed.

NCT04228172 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04228172 about?

NCT04228172 is a clinical study titled "Genotypic Influences on Network Progression in Parkinson's Disease". In this longitudinal study, the investigators will follow Parkinson's disease (PD) patients with and without glucocerebrosidase (GBA) mutations. The investigators hypothesize that the rate of increase in brain network activity over time (network progression rate) is faster in patients with GBA gene ...

What is the current status of trial NCT04228172?

This trial is currently active not recruiting. The enrollment target is 32 participants. The study started on 2020-02-24. Estimated completion is 2026-02-01.

What conditions does trial NCT04228172 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT04228172?

The interventions under investigation include: MRI scan (OTHER), DNA/GeneticTesting (GENETIC), FDG PET scan (RADIATION), Clinical and neuropsychological assessments (OTHER).

Who is sponsoring clinical trial NCT04228172?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04228172 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.